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Background: Adipose tissue-derived stromal stem cells (ASCs) represent a promising regenerative resource for soft
tissue reconstruction. Although autologous grafting of whole fat has long been practiced, a major clinical limitation
of this technique is inconsistent long-term graft retention. To understand the changes in cell function during the
transition of ASCs into fully mature fat cells, we compared the transcriptome profiles of cultured undifferentiated
human primary ASCs under conditions leading to acquisition of a mature adipocyte phenotype.
Methods: Microarray analysis was performed on total RNA extracted from separate ACS isolates of six human adult
females before and after 7 days (7 days: early stage) and 21 days (21 days: late stage) of adipocyte differentiation
in vitro. Differential gene expression profiles were determined using Partek Genomics Suite Version 6.4 for analysis
of variance (ANOVA) based on time in culture. We also performed unsupervised hierarchical clustering to test for
gene expression patterns among the three cell populations. Ingenuity Pathway Analysis was used to determine
biologically significant networks and canonical pathways relevant to adipogenesis.
Results: Cells at each stage showed remarkable intra-group consistency of expression profiles while abundant
differences were detected across stages and groups. More than 14,000 transcripts were significantly altered during
differentiation while ~6000 transcripts were affected between 7 days and 21 days cultures. Setting a cutoff of
+/-two-fold change, 1350 transcripts were elevated while 2929 genes were significantly decreased by 7 days.
Comparison of early and late stage cultures revealed increased expression of 1107 transcripts while 606 genes
showed significantly reduced expression. In addition to confirming differential expression of known markers of
adipogenesis (e.g., FABP4, ADIPOQ, PLIN4), multiple genes and signaling pathways not previously known to be
involved in regulating adipogenesis were identified (e.g. POSTN, PPP1R1A, FGF11) as potential novel mediators of
adipogenesis. Quantitative RT-PCR validated the microarray results.
Conclusions: ASC maturation into an adipocyte phenotype proceeds from a gene expression program that
involves thousands of genes. This is the first study to compare mRNA expression profiles during early and late stage
adipogenesis using cultured human primary ASCs from multiple patients.
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Table 1 Taqman Probes used for QRT-PCR Assay
PROBES TAQMAN SPECIFIC TRANSCRIPT
ASSAY ACCESSION NO
Adiponectin Hs00605917_m1
Fatty acid binding protein (FABP4) Hs01086177_m1
Fibroblast growth factor-1 (FGF1) Hs00265254_m1
Fibroblasts growth factor-11 (FGF11) Hs00182803_m1
Hairy and enhancer of split-1 (Hes1) Hs00172878_m1
Perilipin 4 (PRLN4) Hs00287411_m1
Periostin (POSTN) Hs00170815_m1
Protein phosphatase 1, regulatory
(inhibitor) subunit 1A (PPP1R1A)
Hs00410058_m1
Radical S-adenosyl methionine domain
containing 2 (RSAD2)
Hs00369813_m1
GAPDH Hs02758991_g1
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Adipose-derived stem cells (ASCs) have become one of
the most widely studied adult stem cell populations for
soft tissue engineering and regenerative medicine appli-
cations since their isolation and characterization over a
decade ago [1]. ASCs offer several advantages compared
to other stem cell sources including an abundant autolo-
gous source, minimally-invasive harvesting, significant
proliferative capacity in culture and multi-lineage poten-
tial. Although autologous ASC application in the United
States has yet to be FDA-approved, clinical [2, 3] and
pre-clinical studies [4–6] throughout the world have
underscored its potential.
To date, the most significant progress for clinical applica-
tion of ASCs has been in the area of whole fat grafting.
However, long-term fat graft survival and durability remain
unpredictable and the use of ASCs to enhance the long-
term viability of fat grafts is an area of active interest. It is
hypothesized that ASCs potentiate the viability of mature
adipocyte grafts both as a cell source for de novo adipogen-
esis and through production of local growth factors. While
animal studies demonstrate improved tissue volumes after
fat grafting enriched with ASCs [4, 5], definitive studies are
lacking that show that graft supplementation with ASCs is
superior to standard fat grafting in humans. Understanding
the molecular mechanisms that regulate the differentiation
of ASCs to an adipocyte lineage can be helpful in formulat-
ing novel therapies to enhance the utility and stability of
adipose tissue grafts. Limited data address temporal gene
expression changes during adipogenesis. The murine 3 T3-
L1 cell line is well characterized in vitro model for studying
the conversion of preadipocytes into adipocytes since deriv-
ation in the early 1960’s by Howard Green [7]. Several stud-
ies [8–12] have utilized this cell line for examination of
gene expression changes during adipocyte development as
these cells readily accumulate lipid upon differentiation. In
addition, murine [13] and porcine [14] adipose tissues have
been examined for transcriptional profile comparisons with
human adipose tissue. However, with the recent discovery
of human ASCs [1, 15], these multi-potent stem cells have
become the main focus for analyzing transcriptional and
protein profile changes during differentiation [16–19].
To better understand the cellular and physiologic pro-
cesses during the transition of ASCs toward the adipo-
cyte phenotype, we characterized and compared the
transcriptome profiles of undifferentiated human pri-
mary ASCs prior to and after undergoing adipocyte dif-
ferentiation for 7 (early stage) and 21 days (late stage)
under conditions inducing adipogenic differentiation.
Methods
Adipose tissue collection
Subcutaneous adipose tissue was harvested during elective
abdominoplasties from six human adult female patients.Mean age of the patients was 43.7 (±10.3) years and mean
BMI was 37.8 (±15.1). All subjects were in good health
and free from diabetes. These studies were carried out
under an exempt protocol with no consent required from
the subjects as it is discarded tissue used without any per-
sonal identifying information. Protocol was approved by
the University of Pittsburgh’s Institutional Review Board
under the IRB protocol # PRO13090506. These studies
have been conducted according to the principles expressed
in the Declaration of Helsinki.Human adipose-derived stem cell (ASC) isolation
Adipose-derived stem cells (ASCs) were isolated from ab-
dominal subcutaneous adipose tissue as previously de-
scribed [1] with minor modifications. Briefly, adipose
tissue was first minced with large surgical scissors and
digested in Hank’s Balanced Salt Solution (Invitrogen,
Carlsbad, CA) containing 3.5 % bovine serum albumin
(Millipore, Charlottesville, VA) and 1 mg/ml collagenase
type-II (Worthington Biochemical Corp., Lakewood, NJ).
The tissue was then gently shaken in a 37 °C water bath
for 40 min and centrifuged at 180×g for 10 min. The
resulting cellular pellet (= stromal vascular fraction, SVF)
was then resuspended in ammonium chloride-based
erythrocyte lysis buffer (Beckman Coulter, Miami, FL),
and centrifuged at 180×g for 10 min. Next, the SVF pellet
was resuspended in 20 ml ASC plating media (pH 7.4,
DMEM:DMEM/F12 (1:1), 10 % fetal bovine serum (FBS),
1 % penicillin/streptomycin, Invitrogen; 0.5 % Fungizone,
Fisher Scientific, Pittsburgh, PA; 0.001 % dexamethasone,
Sigma-Aldrich, St. Louis, MO), disaggregated through
sterile cotton gauze (12-ply, Fisher Scientific), then plated
on tissue culture-treated flasks (BD Biosciences, Franklin
Lakes, NJ). After overnight incubation, non-adherent cells
were removed by gentle aspiration and fresh ASC plating
medium was added to the flasks. ASCs were maintained
(a)
(b)
Fig. 1 (See legend on next page.)
Satish et al. BMC Medical Genomics  (2015) 8:41 Page 3 of 12
(See figure on previous page.)
Fig. 1 Intracellular lipid accumulation in undifferentiated, 7- and 21-day differentiated ASCs: a Phase contrast images of cells (10x magnification)
are presented in the top panel and the corresponding AdipoRed stained images are shown in the bottom panel. These are representative
photographs from two independent experiments each performed in duplicate. b Quantification of intracellular lipid showed significantly
increased accumulation of lipid droplets in 21-day differentiated ASCs versus undifferentiated and 7-day differentiated ASCs. Values represent
mean ± SEM of two independent experiments performed in triplicate. Statistical analysis was performed using Student’s t test and p < 0.05 was
considered significant
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vested and stored in liquid N2 until use.Adipogenic differentiation
Asynchronous ASCs (passage 1) from each patient were
seeded on tissue culture treated flasks (BD Biosciences) at
approximately 80 % confluence and cultured with ASC
plating media until nearly 100 % confluence. Plating media
was then gently aspirated and replaced with adipocyte dif-
ferentiation medium (Zen-Bio Inc., Research Triangle
Park, NC). The differentiation media was replaced every
other day for either 7 or 21 days. The cells were main-
tained in the differentiation medium throughout the entire
time period of differentiation. Cells cultured in ASC plat-
ing media served as undifferentiated Day 0 controls. At
the end of each time period, ASC differentiation (to ma-
ture adipocytes) was quantified by intracellular lipid accu-
mulation using the AdipoRed Assay Reagent as described
below. The differentiation media was replaced every other
day for 21 days.Adipored assay
Undifferentiated ASCs were plated at a density of 5 × 105
cells/35 mm dish and at 1 × 103 cells/well in 96-well plates
and allowed to differentiate for a period of 7 and 21 days.
Cells cultured in ASC plating media served as Day 0 con-
trols. On days 0, 7 and 21, cells were treated with Adi-
poRed (Lonza Inc., Allendale, NJ), and total lipid content
was determined according to the manufacturer’s protocol.
In brief, cells grown in 35 mm dishes were washed twice
with phosphate-buffered saline (PBS), followed by the
addition of 2 ml of PBS containing 60 μl of AdipoRed
reagent and incubated for 15 min at room temperature.
AdipoRed becomes fluorescent when partitioned in a
hydrophobic compartment. Phase contrast and fluores-
cence images were captured using an inverted Nikon
Eclipse TE2000-U fluorescent microscope (Nikon Inc.
Melville, NY). Cells grown in 96 well plates were washed
twice with PBS followed by the addition of 200 μl of PBS
containing 5 μl of AdipoRed reagent and incubated in
room temperature for 15 min. The fluorescence of each
well was measured using a Tecan Infinite M200 PRO
(Tecan US, Morrisville, NC) at 485 nm excitation and
572 nm emission wavelengths.RNA extraction
Total RNA from undifferentiated ASCs, and cells sub-
jected to 7 and 21-day differentiated protocols was ex-
tracted using the RNeasy Mini Kit (Qiagen Inc., Valencia,
CA) according to the manufacturer's instructions. The
concentration of the extracted RNA was quantified using
a Nanodrop ND-1000 Spectrophotometer (NanoDrop,
Wilmington, DE) and only samples with absorption ratio
260/280 ≥ 1.8 were subjected to further processing. The
purified RNA samples were characterized for size and in-
tegrity using the Agilent 2100 Bioanalyzer (Agilent Tech-
nologies, Santa Clara, CA) to ensure sample quality and
absence of degradation (RIN value > 8.0).
Microarray
Total RNA purified from undifferentiated ASCs (n = 5),
as well as cells subjected to differentiation conditions for
7 days (n = 4) and 21 days (n = 6) were subjected to array
analysis. In vitro transcription was performed using the
Ambion Message Amp Premier Enhanced assay protocol
(Ambion Inc, Austin, TX) starting with 500 ng of puri-
fied total RNA. Confirmation of cRNA diversity was ob-
tained using the Bioanalyzer 2100 to characterize sample
yield, integrity, and size diversity against a Universal Hu-
man Reference RNA (Stratagene, La Jolla, CA). Fifteen
micrograms of purified, amplified, biotin labeled cRNA
was fragmented and hybridized onto Affymetrix Human
Genome HGU133A plus 2.0 arrays (Affymetrix Corp.,
Santa Clara, CA) for 18 h. Washing, staining and scan-
ning of arrays was performed on the Affymetrix Fluidics
Station 450 and Scanner 3000 immediately after comple-
tion of hybridization. The preparation of cRNA and
hybridization to microarrays was performed by Gene
Logic Inc. Data quality was assessed by using pre-
normalized data to generate degradation plots and com-
pare 3′–5′ rations for all the actin and GAPDH probesets
[20]. Microarray data was processed using the Expression
Console (Affymetrix) with signal intensity calculated by
Microarray Suite version 5.0 (MAS 5.0).
Microarray data analysis
Data analysis to determine differential gene expression pro-
files was performed by importing MAS 5.0 intensity data
into the Partek Genomics Suite Version 6.4 (St. Louis, MO)
for analysis of variance (ANOVA) based on time in culture.
Fig. 2 Hierarchical clustering and heat map analysis of individual
gene expression profiles: A heat map depiction of the transcriptomic
profiles of all samples analyzed by microarray is presented. Red bars
indicate relatively high signal intensity for the gene product in question,
with blue representing lower intensity and grey intermediate. Clustering
of the samples is indicated by the dendrogram on top; it is apparent
that all 5 undifferentiated samples cluster together (have the highest
degree of similarity with each other), and the same is true for
the 4 7-day differentiated samples and the 6 21-day differentiated
samples. UD 1–5: undifferentiated ASCs; 7days 1–3, 5: 7-day
differentiated ASCs; 21 day 1–6: 21-day differentiated ASCs
Table 2 Identification of Differentially Regulated Genes
Comparing 7 day vs Undifferentiated cells and 21 day vs
7 day cells
Days Upregulated Genes
(2 fold and above)
Downregulated Genes
(0.5 fold and below)
7 day vs Undiff 1350 2929
21 day vs 7 day 1107 606
Satish et al. BMC Medical Genomics  (2015) 8:41 Page 5 of 12Post hoc testing employed the Fisher’s exact test adjusted
to correct for false discovery rates (q < 0.05) associated with
multiple testing. We also performed unsupervised hierarch-
ical clustering to test for gene expression patterns among
the three cell populations. In order to determine biologic-
ally significant networks and canonical pathways relevant
to adipogenesis, we utilized Ingenuity Pathway Analysis
(IPA Suite, Ingenuity Systems; http://www.ingenuity.com,
Mountain View, CA). Only differentially expressed genes
(−2.0 > fold-change >2.0; q value <0.05) were included in
each IPA core analysis. Genes were mapped to genetic
networks and statistically ranked based on the number of
differentially expressed genes among the eligible mole-
cules in the network. Microarray data sets obtained
through this study will be deposited in NCBI’s Gene Ex-
pression Omnibus (GEO).
Quantitative reverse transcription- PCR
The protocols for reverse transcription reactions and real-
time PCR were previously described [21]. Pooled, total
RNA (400 ng) from each of the three cell populations (un-
differentiated ASCs, 7- and 21-day differentiated ASCs)
were mixed with 300 ng of random primers (Invitrogen
Corporation) and reverse transcribed in 60 μl reactions.
Real-time PCR amplification and detection of templates
were performed in triplicate assays carried out on an Ap-
plied Biosystems PRISM 7900HT system using Applied
Biosystems Taqman transcript-specific assays as listed in
Table 1. Using the comparative critical cycle (Ct) method
and using glyceraldehyde phosphate dehydrogenase
(GAPDH) as the endogenous control, the expression
levels of the target genes were normalized using a 95 %
confidence interval. The relative expression of the genes
from each sample set was averaged and statistical analysis
for significance was performed using a Student’s t-test.
Results
Adipored confirmation of differentiation to adipocyte
lineage
The AdipoRed assay was employed to monitor accumu-
lation of intracellular lipid at 7 and 21 days of adipo-
genic cell culture media consistent with a protocol
directing differentiation into the adipocyte phenotype.
Under the microscope 21-day differentiated cells showed
increased fine red-colored lipid droplets bounded by the
cell membrane compared to both undifferentiated and
7-day differentiated ASCs (Fig. 1a). Quantitative analysis
of intracellular lipid accumulation based on cellular
fluorescence confirmed the increased levels of lipid
present with time in differentiation media (Fig. 1b).
Microarray analysis of differential gene expression
Comprehensive RNA degradation plots of individual mean
probe intensities indicated comparable transcript integrity
(a) (b)
(c) (d)
(e) (f)
(g) (h)
(i)
Fig. 3 (See legend on next page.)
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Fig. 3 Relative expression levels of select genes as determined by microarray: Histogram presentations of the relative expression levels of
(a) FABP4 (b) ADIPOQ (c) PLIN4 (d) FGF1 (e) FGF11 (f) HES1 (g) RSAD2 (h) PPP1R1A (i) POSTN as quantified by microarray are shown. Signal
intensities for each gene product are expressed in arbitrary units after background subtraction. Statistical significance was determined by
Student’s t test and p value < 0.05 was considered significant
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Box plot analysis of individual array sample intensities
demonstrated comparable dispersion of the individual data
sets, regardless of patient source, eliminating the need for
additional normalization based on constitutive markers
and secondary smoothing of the raw intensity data prior
to statistical evaluation (Additional file 1b). Furthermore,
these results also indicated that each sample set exhibited
a comparable broad diversity of transcripts unaffected by
noise and not skewed by outliers.
Gene expression in 0 day control (undifferentiated)
cells differed significantly from those harvested after 7
and 21 days of differentiation (ANOVA: p < 0.02). Post-
hoc testing revealed that approximately 14,000 tran-
scripts were significantly altered between control and
either day 7 or day 21 cultures. Comparison of expres-
sion values between day 7 and day 21 revealed that ap-
proximately 6,000 different transcripts were significantly
altered between these two time points after correction
for false discovery (q < 0.05). In comparing expression
between day 7 and day 0, 1350 genes exhibited > two-
fold increase while 2929 genes fell more than two-fold.
Comparing 21 day vs 7 day differentiated cells, expres-
sion levels of 1107 transcripts increased and 606 genes
decreased (Table 2 and Additional files 2 and 3). These
data indicate that ASC differentiation in vitro is a dy-
namic and complex process affecting a dominant por-
tion of the transcriptome. Unsupervised hierarchical
clustering reinforced these findings with each cell classi-
fication forming discriminant clusters (Fig. 2). There
were notable differences in the expression of some tran-
scriptional regulators involved in maintenance of stem
cell pluripotency on Day 7 and Day 21 vs undifferenti-
ated controls and the shift from a stem cell phenotype
to a mature adipocyte was accompanied by a significant
reduction in NANOG expression (data not shown).
Quantitative RT-PCR analysis of selected transcripts
We performed direct quantitation of nine selected gene
products by real-time RT-PCR to validate the microarray
findings. Genes were selected based on their established
relevance to adipocyte biology, or were included to val-
idate their heretofore unknown importance to adipocyte
maturation. In every case, a strong correspondence be-
tween the microarray and real time RT-PCR data was
observed (Figs. 3 and 4).
Expression levels of FABP4 (fatty acid binding protein 4
or adipocyte protein 2), ADIPOQ (adiponectin) and PLIN4(perilipin), known markers for differentiated adipocytes,
were significantly increased at 7 and 21 days in culture al-
beit with a statistically significant decline after day 7
(Figs. 3a,b,c and 4a,b,c). Similarly, PPP1R1A (protein phos-
phatase 1, regulatory (inhibitor) subunit 1A), was markedly
elevated at 7 days versus undifferentiated controls, but fell
back to baseline by 21 days (Figs. 3h and 4h). We also in-
vestigated fibroblast growth factors identified as differen-
tially expressed by the microarray. Fibroblast growth factor
1 (FGF1) was initially decreased in 7days culture but
showed a significant increase well above the 0day baseline
at 21 days in culture. In contrast, fibroblast growth factor
11 (FGF11) showed both an initial increase at 7 days, and
a further increase at 21 days (Figs. 3d,e & 4d,e).
Two genes, periostin (POSTN) and HES1 (hairy and
enhancer of split-1), exhibited decreased expression in
both 7days and 21day cultures relative to undifferentiated
cultures: (Figs. 3f 4f 3i & 4i). Finally, RSAD2 (radical
S-adenosyl methionine domain containing 2) showed
no significant change after 7 days of culture but was
dramatically elevated at 21 days (Figs. 3g & 4g).
Identification of significant biological pathways using
ingenuity analysis
To investigate the biological function of differentially
modulated genes, transcripts reflecting statistically sig-
nificant alterations (q < 0.05, −2 > fold-change > +2) were
interrogated by Ingenuity Pathway Analysis (IPA). In
comparing 7days vs undifferentiated cells, and 21day vs
7days cultures, the top five canonical pathways, top net-
works, top molecules, and top transcription factors iden-
tified are listed in Tables 3a–d and 4a–d respectively.
For 7 day versus undifferentiated ASCs, most of the top
canonical pathways and networks identified in this study
have been previously shown to play a role in adipogene-
sis, with four of the five networks explicitly involved in
lipid metabolism. However, examination of the top mol-
ecules for the first time identifies CXCL6, a CXC che-
mokine previously shown to have angiogenic properties,
as a potential regulator of adipogenesis, and also identi-
fies thrombospondin as potentially important (Table 3c).
Analysis of data on d21 vs d7 was interesting in that the
most prominent pathway, TREM-1 (triggering receptor
expressed on myeloid cells 1) signaling, is known to acti-
vate a cascade of events associated with inflammatory
processes. Top molecules identified in this comparison
comprised interferon-induced genes such as RSAD2,
HECT and RLD domain containing E3 ubiquitin protein
(a) (b)
(c) (d)
(e) (f)
(g) (h)
(i)
Fig. 4 (See legend on next page.)
Satish et al. BMC Medical Genomics  (2015) 8:41 Page 8 of 12
(See figure on previous page.)
Fig. 4 Confirmation of select gene expression by direct quantitative RT-PCR assay: The results of direct quantitative RT-PCR assays measuring
relative message levels of (a) FABP4 (b) ADIPOQ (c) PLIN4 (d) FGF1 (e) FGF11 (f) HES1 (g) RSAD2 (h) PPP1R1A (i) POSTN are shown as
histograms. Relative values for each transcript were normalized by internal control (GAPDH), and are shown here in each instance with baseline
expression in undifferentiated ASCs set at a relative value of “1”. Values represent mean ± SEM of two independent experiments performed in
triplicate. p < 0.05 was considered significant. In all cases a strong concordance was seen in the patterns of gene expression measured by
microarray and measured by direct qRT-PCR
Satish et al. BMC Medical Genomics  (2015) 8:41 Page 9 of 12ligase family member 6 (HERC6), along with the chemo-
kine CCL5 and tumor necrosis factor superfamily mem-
ber 15 (TNFSF15) (Table 4c). Transcription factor
analysis predicted that PPAR and SREB transcription
factors, key regulators of adipocyte physiology, played
prominent roles in 7days vs undifferentiated cultures
(Table 3d), but did not have a dominant role in the tran-
sition from 7days to 21day (Table 4d).
Discussion
Human primary adipose-derived stem cells exhibited vast
changes in mRNA expression profiles throughout trans-
formation (~14,000 transcripts) from undifferentiated, stem
cells (0 day) to late stage (21 day) lipid-laden, adipocytes of
mature phenotype. Despite these dynamic transitions, cells
in each stage demonstrated consistent intra-group tran-
scriptome profiles and distinct expression pattern clusters.
It is important to consider that the original stromal vascu-
lar fraction (SVF) from which our ASC cultures were de-
rived comprised a mix of at least four different constituent
cell types, and transcript levels represented summated ex-
pression of these cell sub-populations. However, the most
prevalent and proliferative cell type within the SVF is theTable 3 Top Canonical Pathways (a) and Top Networks (b) Identified
Undifferentiated Cells: Top Molecules (c) and Top Transcription Facto
7 day vs Undifferentiated Cells
(a) (b)
Name p-value Associated Network Functions
LPS/IL-1 Mediated
Inhibition of RXR Function
6.17E-08 Lipid Metabolism, Small Molecule
Biochemistry, Gastrointestinal Disease
Pyruvate Metabolism 6.28E-08 Drug Metabolism, Protein Synthesis, C
Death
Fatty Acid Biosynthesis 3.49E-07 Lipid Metabolism, Molecular Transpo
Small Molecule Biochemistry
TR/RXR Activation 1.65E-06 Lipid Metabolism, Small Molecule
Biochemistry, Energy Production
Glycolysis/Gluconeogenesis 1.34E-05 Lipid Metabolism, Molecular Transpo
Small Molecule Biochemistrypre-adipocyte cell, typically characterized as CD31(−)/
CD34(+), and this unique primary cell culture model likely
reflects the dominant influence of those ASCs [22].
Our data confirm the importance of several key
adipocyte-specific genes known to be downstream tar-
gets of PPARG including FABP4, ADIPOQ, and PLIN4.
These transcripts dramatically increased in expression
after 7 days but returned toward baseline by 21 days,
suggesting a critical role for these genes during induc-
tion of the adipocyte differentiation program but dimin-
ution of importance in maintenance of the mature
phenotype. A similar pattern of expression was seen in
PPP1R1A transcripts, the inhibitory regulatory subunit
1A of protein phosphatase 1. This gene is important in
glycogen metabolism [23], and has been proposed as a
marker for pancreatic β-cell injury [24]. Elevated
PPP1R1A expression at 7 days suggests that inhibition
of protein phosphatase activity contributes to early
stages of differentiation in ASCs and supports the possi-
bility that chemical inhibitors of protein phosphatase 1
may drive ASCs toward a mature phenotype.
We also characterized the differential expression of
fibroblast growth factor 1 (FGF1) and FGF11 duringUsing Ingenuity Pathway Analysis in Comparing 7 day vs
rs (d) Identified Using Ingenuity Pathway Analysis in Comparing
(c) (d)
Score Name Exp.Value Transcription
Regulator
P-value of
overlap
Predicted
Activation
State
39 PCK1 −40.310 PPARG 2.59E-22 Activated
ell 39 THRSP −31.613 PPARA 1.02E-20 Activated
rt, 36 CA3 −28.877 SREBF1 5.80E-18 -
35 BBOX1 −28.336 SREBF2 1.60E-10 -
rt, 35 GPD1 −26.297 PPARGC1A 3.23E-10 -
PDE3B −19.778
SCD −17.679
CXCL6 −17.037
LGALS12 −16.318
FABP4 −14.682
Table 4 Top Canonical Pathways (a) and Top Networks (b) Identified Using Ingenuity Pathway Analysis in Comparing 21 day vs 7 day
(a) (b) (c) (d)
Name p-value ID Associated Network Functions Score Name Exp.Value Transcription
Regulator
P-value
of
overlap
Predicted
Activation
State
TREM1 Signaling 1.49E-08 1 Dermatological Diseases and
Conditions, Genetic Disorder,
Organismal Injury and
Abnormalities
43 RSAD2 −33.001 IRF7 5.14E-37 -
Communication between
Innate and Adaptive
Immune Cells
2.27E-08 2 Cellular Response to Therapeutics,
Cellular Assembly and
Organization, Cellular Compromise
33 CMPK2 −16.965 STAT3 2.26E-27 -
Hepatic Fibrosis/Hepatic
Stellate Cell Activation
6.52E-08 3 Inflammatory Disease, Neurological
Disease, Cellular Function and
Maintenance
31 ORM1/
ORM2
−16.674 NFkB
(complex)
2.48E-26 -
Interferon Signaling 8.34E-08 4 Lipid Metabolism, Small Molecule
Biochemistry, Molecular Transport
31 CCL5 −15.185 IRF1 1.73E-22 -
Role of Pattern Recognition
Receptors in Recognition of
Bacteria and Viruses
2E-07 5 Cellular Assembly and
Organization, Cellular Function and
Maintenance, Cellular Movement
31 LOC152742 −13.169 IRF3 5.54E-22 -
HERC6 −11.919
MX1 −11.250
OAS3 −11.105
IFI27 −10.472
TNFSF15 −10.235
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ously been identified as potent adipogenic factors se-
creted from adipose-derived microvascular endothelial
cells (MVECs). FGF1 stimulates all stages of adipogene-
sis including preadipocyte proliferation, commitment
and differentiation [25]. A role for FGF1 in adipose is
also supported by the demonstration of defects in vascu-
lature and adipocyte size in the fat depots of FDF1 defi-
cient mice [26]. Its low levels after 7 days of culture
followed by a distinct increase at 21 days suggests that
this factor plays a critical role in establishing and main-
taining the mature adipocyte phenotype. FGF11 expres-
sion increased at the 7 day time point and rose further
by 21 days. This is the first report of changes in FGF11
associated with adipogenesis. Elevated FGF11 expression
has been noted in neural precursor cells [27] and cardio-
myocytes [28] and increased FGF11 has also been asso-
ciated with lymphatic spread of an oral squamous cell
carcinoma cell line [29].
Another gene product showing dramatically increased
late stage expression is RSAD2, (radical S-adenosyl me-
thionine domain-containing protein 2) commonly known
as viperin. Viperin is an interferon-inducible gene active
against a range of viral pathogens, including dengue, West
Nile, human immunodeficiency virus (HIV), and cyto-
megalovirus (CMV). No role for viperin in adipogenesis
has previously been described, but viperin protein can dis-
rupt lipid rafts increasing lateral mobility of the plasmamembrane [30], and is known to localize to lipid droplets
in cells. Its anti-viral function in hepatitis C virus is
thought to be associated with the ability to ameliorate
viral replication in lipid droplets [31]. RSAD2 is also a
candidate gene that maps to a chromosome 12 quantita-
tive trait locus associated with adipose composition [32].
Our 21 day differentiated adipocytes are rich depositories
of accumulated lipids and it may be that viperin is con-
comitantly synthesized and accumulated in concert with
this process which needs to be validated.
We identified a marked inhibition of HES1 and periostin
expression during the adipocyte differentiation process.
HES1 is a powerful basic helix-loop-helix transcription
factor associated with regulation of tissue specificity dur-
ing development. Reduction in HES1 expression during
differentiation suggests this factor is critical to mainten-
ance of the committed but undifferentiated adipocyte
stem cell. These data are consistent with previous reports
that HES1 expression decreases during adipocyte differen-
tiation in the 3 T3-L1 system in vitro and in vivo [12]
while constitutive over-expression inhibits differentiation
of 3 T3-L1 preadipocytes. Periostin is an extracellular in-
tegrin ligand expressed at high levels in bone and teeth but
involved in a host of cellular and disease processes [33].
Periostin has been implicated in cardiac development and
pathophysiology [34], tumor survival and invasion [35], and
the fibroproliferative disorder Dupuytren’s contracture [36].
A role for periostin in adipogenesis has not previously been
Satish et al. BMC Medical Genomics  (2015) 8:41 Page 11 of 12reported. Exploring the role of HES1 and periostin in adi-
pocyte biology might provide more insights in modulating
the functions of adipocytes.
The magnitude of changes across the transcriptome of
stem cells undergoing differentiation into mature adipo-
cytes in this study was surprising. We were able to con-
firm the role of several genes previously associated with
this process while revealing a number of new transcripts
directly affected. Substantial work remains to classify the
underlying regulatory mechanisms driving the process.
However, the reproducibility of our results across
multiple primary cell isolates at each stage indicates
that this primary cell culture model has the necessary
fidelity for demanding mechanistic studies. The ultim-
ate physiological and clinical significance of these
findings will likely arise from molecular and pharma-
cological manipulation of targets and pathways identi-
fied in this model.
Conclusions
This study for the first time determines differential
mRNA expression profiles during early- and late- adipo-
cyte differentiation from ASC precursors and identifies
multiple new transcripts which may be potential targets
for enhancing the retention of fat grafts.
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